|
ZCCHC11 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.375900E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.143460E-03 |
| Normal-vs-Stage2 |
3.507600E-01 |
| Normal-vs-Stage3 |
6.697200E-01 |
| Normal-vs-Stage4 |
9.286200E-01 |
| Stage1-vs-Stage2 |
2.951400E-01 |
| Stage1-vs-Stage3 |
1.142220E-03 |
| Stage1-vs-Stage4 |
1.156050E-02 |
| Stage2-vs-Stage3 |
2.070800E-01 |
| Stage2-vs-Stage4 |
3.465600E-01 |
| Stage3-vs-Stage4 |
7.883600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.079990E-01 |
| Normal-vs-AfricanAmerican |
1.972240E-01 |
| Normal-vs-Asian |
5.314100E-02 |
| Caucasian-vs-AfricanAmerican |
5.703200E-01 |
| Caucasian-vs-Asian |
1.591990E-02 |
| AfricanAmerican-vs-Asian |
7.514100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.660000E-01 |
| Normal-vs-Female |
9.969200E-04 |
| Male-vs-Female |
2.983500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.775600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.618110E-02 |
| Normal-vs-Age(61-80Yrs) |
1.404750E-01 |
| Normal-vs-Age(81-100Yrs) |
3.352000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.594000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.772000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.706400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.995600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.300300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.134010E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.377600E-03 |
| Normal-vs-Grade 2 |
2.220100E-04 |
| Normal-vs-Grade 3 |
7.677600E-01 |
| Normal-vs-Grade 4 |
4.930000E-02 |
| Grade 1-vs-Grade 2 |
3.520300E-02 |
| Grade 1-vs-Grade 3 |
2.420400E-04 |
| Grade 1-vs-Grade 4 |
1.58669999994476E-06 |
| Grade 2-vs-Grade 3 |
3.835300E-04 |
| Grade 2-vs-Grade 4 |
3.65620000053468E-07 |
| Grade 3-vs-Grade 4 |
3.192400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.21399999997163E-06 |
| Normal-vs-ccB subtype |
3.862000E-01 |
| ccA subtype-vs-ccB subtype |
2.15340000275788E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.188000E-02 |
| Normal-vs-N1 |
4.330600E-01 |
| N0-vs-N1 |
1.609180E-01 |
|
|
